P.A. Andreasen

8.2k citations

48 papers · 7.3k indexed · 2 hit papers · h-index 31

Impact in

Cancer Research top 0.1%
- Protease and Inhibitor Mechanisms
Immunology and Allergy top 0.2%
- Cell Adhesion Molecules Research

Papers in

Cancer Research 39
- Protease and Inhibitor Mechanisms 39
Hematology 27
- Blood Coagulation and Thrombosis Mechanisms 27

Co-authors: Keld Danø Lene Nielsen Lars Skriver J Grøndahl-Hansen Peter Lommer Kristensen Rikke Egelund Heidi Huus Petersen Olli Saksela
Journals: Journal of Biological Chemistry (7 papers)Thrombosis and Haemostasis (4 papers)The Journal of Cell Biology (3 papers)The EMBO Journal (3 papers)Biochimica et Biophysica Acta (BBA) - General Subjects (3 papers)
Partner nations: Denmark United States Sweden

In The Last Decade

P.A. Andreasen

48 papers receiving 7.0k citations

Hit Papers

align trajectories log scale

The plasminogen activation system in tumor growth, invasion, and metastasis 2000 · 799 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2000 Cellular and Molecular Life Sciences
1985 Advances in cancer research

Peers

Countries citing papers authored by P.A. Andreasen

Since Specialization

Citations

This map shows the geographic impact of P.A. Andreasen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P.A. Andreasen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P.A. Andreasen more than expected).

Fields of papers citing papers by P.A. Andreasen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P.A. Andreasen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P.A. Andreasen. The network helps show where P.A. Andreasen may publish in the future.

Co-authorship network

The 25 scholars most cited alongside P.A. Andreasen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with P.A. Andreasen Line = papers co-authored together P.A. Andreasen links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Nucleic Acid Aptamers Against Proteases Current Medicinal Chemistry ·Daniel M. Dupont, Nitin Kohli, Kenneth A. Bøtkjær, P.A. Andreasen	2011	24
2	The influence of glancing angle deposited nano-rough platinum surfaces on the adsorption of fibrinogen and the proliferation of primary human fibroblasts Nanotechnology ·Alireza Dolatshahi‐Pirouz, Cristian Pablo Pennisi, Sune Skeldal, Morten Foss, J. Chevallier, Vladimir Zachar, P.A. Andreasen, Ken Yoshida, Flemming Besenbacher	2009	50
3	Increased performance of secondary clarifiers using dynamic distribution of minimum return sludge rates Water Science & Technology ·Anders Lynggaard-Jensen, P.A. Andreasen, P. Strzelecki, Westall, Rahmi Rahmi, M.C Terrones, V. Teikari, 한재갑	2009	6
4	The plasminogen activation system in tumor growth, invasion, and metastasis Cellular and Molecular Life Sciences ·P.A. Andreasen, Rikke Egelund, Heidi Huus Petersen Hit paper breakdown →	2000	799
5	Prognostic significance of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in primary breast cancer British Journal of Cancer ·Ann Knoop, P.A. Andreasen, Karim Naji, Steinbjørn Hansen, Anne‐Vibeke Lænkholm, Jeffrey Minor, J. Andersen, Jens Overgaard, Carsten Rose	1998	88
6	Urokinase receptor. An activation antigen in human T lymphocytes. The Journal of Immunology ·Anders Nykjær, Bjarne Kuno Møller, Robert F. Todd, Tove Christensen, P.A. Andreasen, Jørgen Gliemann, C. M. Petersen	1994	147
7	Regions involved in binding of urokinase-type-1 inhibitor complex and pro-urokinase to the endocytic alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein. Evidence that the urokinase receptor protects pro-urokinase against binding to the endocytic receptor. Journal of Biological Chemistry ·Anders Nykjær, Lars Kjøller, Robert L. Cohen, Daniel A. Lawrence, B A Garni-Wagner, Robert F. Todd, Anton Jan van Zonneveld, Jørgen Gliemann, P.A. Andreasen	1994	123
8	Diversity in catalytic properties of single chain and two chain tissue-type plasminogen activator Fibrinolysis and Proteolysis ·P.A. Andreasen, Lars C. Petersen, Keld Danø	1991	22
9	Plasminogen activator inhibitor-type 1 in Lewis lung carcinoma Histochemistry and Cell Biology ·Peter Lommer Kristensen, Charles Pyke, Leif R. Lund, P.A. Andreasen, Сергій Михайлович Чевдар	1990	63
10	Lysosomal degradation of receptor-bound urokinase-type plasminogen activator is enhanced by its inhibitors in human trophoblastic choriocarcinoma cells. PubMed ·Poul Henning Jensen, Erik Christensen, Peter Ebbesen, Jørgen Gliemann, P.A. Andreasen	1990	103
11	Urokinase- and tissue-type plasminogen activators are suppressed by cortisol in the involuting prostate of castrated rats Biochemical Journal ·Sebastian Böhm, Paul S. Rennie, Julie Chao, Leif R. Lund, P.A. Andreasen	1990	28
12	Occurrence of the specific plasminogen activator inhibitor of placental type, PAI-2 in ascitic fluid and tumour vessel blood from patients with ovarian carcinoma Fibrinolysis and Proteolysis ·Ingegerd Lecander, Gunilla Martinsson, Bertil Casslén, P.A. Andreasen, Birger Åstedt	1990	5
13	Distinct localizations of urokinase-type plasminogen activator and its type 1 inhibitor under cultured human fibroblasts and sarcoma cells The Journal of Cell Biology ·J Pöllänen, Olli Saksela, 啓平本, P.A. Andreasen, Lene Nielsen, Keld Danø, Antti Vaheri	1987	267
14	cDNA cloning of human plasminogen activator-inhibitor from endothelial cells. Journal of Clinical Investigation ·David Ginsburg, R Zeheb, Angela Yang, Zengzhi Ren, P.A. Andreasen, Lene Nielsen, Keld Danø, R V Lebo, Thomas Gelehrter	1986	303
15	Plasminogen activator inhibitor from human fibrosarcoma cells binds urokinase-type plasminogen activator, but not its proenzyme. Journal of Biological Chemistry ·P.A. Andreasen, Lene Nielsen, Peter Kristensen, J Grøndahl-Hansen, Lars Skriver, Keld Danø	1986	208
16	Plasminogen Activators, Tissue Degradation, and Cancer Advances in cancer research ·Keld Danø, P.A. Andreasen, J Grøndahl-Hansen, Peter Lommer Kristensen, Lene Nielsen, Lars Skriver Hit paper breakdown →	1985	2301
17	Plasminogen activator in psoriatic scales is of the tissue-type PA as identified by monoclonal antibodies British Journal of Dermatology ·W. Schnakenbeck, Lene Nielsen, Peter Lommer Kristensen, Atsuki MURAKAMI, P.A. Andreasen, 進三角	1985	30
18	Inactive proenzyme to tissue-type plasminogen activator from human melanoma cells, identified after affinity purification with a monoclonal antibody. The EMBO Journal ·P.A. Andreasen, Lene Nielsen, J Grøndahl-Hansen, Lars Skriver, Jesper Zeuthen, Ross W. Stephens, Keld Danø	1984	71
19	Monoclonal antibody to human 66,000 molecular weight plasminogen activator from melanoma cells. Specific enzyme inhibition and one-step affinity purification. The EMBO Journal ·Lene Nielsen, Kazuhide Shirai, P.A. Andreasen, Lars Skriver, Keld Danø, Jesper Zeuthen	1983	58
20	Aqueous two-phase partition studies of the glucocorticoid receptor activation and pH-dependent changes of rat liver glucocorticoid-receptor complex in partly purified preparations Biochimica et Biophysica Acta (BBA) - General Subjects ·P.A. Andreasen, W. Ian P. Mainwaring	1980	12

About P.A. Andreasen

P.A. Andreasen is a scholar working on Cancer Research, Hematology, Immunology and Allergy, Filtration and Separation and Genetics, having authored 48 papers that have together received 7.3k indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (39 papers), Blood Coagulation and Thrombosis Mechanisms (27 papers), Cell Adhesion Molecules Research (12 papers), Peptidase Inhibition and Analysis (9 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (5 papers), Enzyme Production and Characterization (4 papers), Blood properties and coagulation (3 papers) and Analytical Chemistry and Chromatography (3 papers). The work is most often cited by research in Cancer Research (5.1k citations), Immunology and Allergy (1.7k citations), Hematology (3.1k citations), Oncology (1.6k citations) and Genetics (599 citations). P.A. Andreasen has collaborated with scholars based in Denmark, United States and Sweden. Frequent co-authors include Keld Danø, Lene Nielsen, Lars Skriver, J Grøndahl-Hansen, Peter Lommer Kristensen, Rikke Egelund, Heidi Huus Petersen, Olli Saksela, Anders Nykjær and Marikki Laiho. Their work appears in journals such as Journal of Biological Chemistry, Thrombosis and Haemostasis, The Journal of Cell Biology, The EMBO Journal and Biochimica et Biophysica Acta (BBA) - General Subjects.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact